The Internet Has Made Health Anxiety Worse Than Ever
“Don’t google your cancer,” the oncology nurse said to me as she drew my blood ahead of my first round of chemotherapy. It was 2006 and I was 17 years old. I was very confused by the emphasis she put on this advice. Still, I took the print-out of “safe” web addresses she gave me home and pinned it on the noticeboard in the kitchen, where it stayed, ignored, as I slowly progressed through six months of cancer treatment.
[time-brightcove not-tgx=”true”]
I was confused because the opportunities for me to use the internet to research my recent diagnosis of Hodgkin’s Lymphoma,...
Source: TIME: Health - April 24, 2024 Category: Consumer Health News Authors: Caroline Crampton Tags: Uncategorized freelance Source Type: news
‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study showsThe NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease – a development charities are hailing as the biggest breakthrough in decades.Gliomas are the most common type of brain cancer in children but experts say the standard treatment of chemotherapy can be brutal and gruelling, and also carries the risk of side-effects such as weight loss, seizures and headaches.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 24, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Cancer Children's health National Institute for Health and Care Excellence England NHS UK news Society Medical research Science Source Type: news
New Targeted Drug Approved for Low-Grade Glioma in Kids
(MedPage Today) -- The FDA granted accelerated approval to tovorafenib (Ojemda) for children 6 months and up with relapsed or refractory low-grade glioma and BRAF-altered tumors, the agency announced on Tuesday.
It represents the first systemic... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 24, 2024 Category: American Health Source Type: news
FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutati (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 23, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Sophie Kinsella, ‘Shopaholic’ Author,’ Says She Has Brain Cancer
The author of the best-selling book series said she had been undergoing treatment for glioblastoma, an aggressive brain tumor, after a diagnosis in 2022. (Source: NYT Health)
Source: NYT Health - April 17, 2024 Category: Consumer Health News Authors: Emily Schmall and Dani Blum Tags: Brain Cancer Books and Literature Writing and Writers Kinsella, Sophie Source Type: news
PET tracer for gliomas under expedited review
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas.
Pixclara was developed by researchers at the University of California, San Francisco. The tracer reveals the activity of specific transporter proteins known as LAT1 and LAT2, which are highly active in brain regions with gliomas. The technique can help determine if a glioma is truly progressing or undergoing a treatment-induced change, known as pseudo-progression, where standard MRI is often inconclusive, the company said.
Pi...
Source: AuntMinnie.com Headlines - April 17, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Molecular Imaging Source Type: news
Doctors thought woman, 77, had cancer... then they discovered she had a brain-eating amoeba
An elderly woman in rural China died from the rare brain-eating amoeba Balamuthia mandrillaris, which doctors initially mistook for a brain tumor. The parasite has infected just 200 people worldwide. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2024 Category: Consumer Health News Source Type: news
Mahbod Moghadam, who rose to fame as the co-founder of Genius, has died
Mahbod Moghadam, the controversial, never-boring co-founder of Genius and Everipedia, as well as an angel investor, passed away last month at age 41 owing to “complications from a recurring brain tumor,” according to a post attributed to his family and published on Genius. The startup world…#mahbodmoghadam #genius #everipedia #joshconstine #moghadam #rapgenius #muckercapital #helladoge #communistagram #spotify (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
French-led team unveils 11.7 tesla MRI scans of human brain
A research group based in Saclay, near Paris, has taken the wraps off what it claims are the world's first MRI scans of the human brain in vivo taken at a field strength of 11.7 tesla. President Emmanuel Macron has congratulated the researchers on social media.
"The first images surpassed our expectations, giving after just four minutes, mind-blowing brain images without any artifacts, with superb tissue contrast and resolution, which represents a volume equivalent to a few thousand neurons," Denis Le Bihan, PhD, founding director of the NeuroSpin research facility and founder of Iseult Project of the French Alternative E...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Philip Ward Tags: MRI Source Type: news
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes?
(MedPage Today) -- Insulins, SGLT2 inhibitors, and GLP-1 receptor agonists can likely be manufactured for prices "far below" their current prices, according to an economic evaluation of manufacturing costs in JAMA Network Open.
In related news... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 2, 2024 Category: Endocrinology Source Type: news
Hormone Drugs and Brain Tumors; Push to Ban Some Decaf Coffees; $10 Million Reward
(MedPage Today) -- Note that some links may require registration or subscription.
Prolonged use of progestogen hormone drugs -- widely used for endometriosis and polycystic ovary syndrome -- was associated with an increased risk of intracranial... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 28, 2024 Category: American Health Source Type: news
Schoolboy, 7, is diagnosed with an inoperable brain tumour which kills most sufferers within a year after he kept bumping into furniture
Aubrey Rothery's parents, thought something was off when the Devon-based family noticed their seven-year-old kept losing his balance and bumping into things. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2024 Category: Consumer Health News Source Type: news
Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors
THURSDAY, March 28, 2024 -- The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns.Depo-Provera (medroxyprogesterone acetate) increased... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 28, 2024 Category: General Medicine Source Type: news
Hormone medication could increase risk of brain tumours, French study finds
Patients taking certain progestogens as a contraceptive or for gynaecological conditions may be more likely to develop growths, researchers sayMillions of women around the world who use certain hormone drugs for contraception and to manage conditions such as endometriosis may have a raised risk of rare, usually benign, brain tumours, researchers say.Scientists found that prolonged use of certain progestogen medications was linked to a greater risk of meningioma, which are tumours (usually noncancerous) that form in tissues around the brain.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 27, 2024 Category: Science Authors: Ian Sample Science editor Tags: Women's health Contraception and family planning Menopause Medical research Cancer Science Source Type: news
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment
Novocure stock surged Wednesday after its medtech device nearly doubled the length of time patients with brain tumors lived before worsening. The post Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment appeared first on Investor's Business Daily. (Source: Reuters: Health)
Source: Reuters: Health - March 27, 2024 Category: Consumer Health News Source Type: news
